Clinical characteristics, biomarkers and prevalence of cerebral amyloid angiopathy in Alzheimer’s disease: Applying the Boston criteria v2.0 in a memory clinic population
The prevalence of CAA among AD patients was lower than pathology-based estimates. AD patients from memory clinics may exhibit comparable cognitive profiles and similar patterns of AD biomarkers regardless of their CAA probability. These findings underscore the importance of further research in the application of the Boston criteria in memory clinic patients with AD.
Authors
- Karl‐Olof Lövblad (ORCID: https://orcid.org/0000-0003-2768-9779)
- Augusto J. Mendes (ORCID: https://orcid.org/0000-0002-9497-0707)
- Aurélien Lathuilière (ORCID: https://orcid.org/0000-0002-5191-5214)
- Federica Ribaldi (ORCID: https://orcid.org/0000-0001-9208-4472)
- Christian Chicherio (ORCID: https://orcid.org/0009-0004-9845-2618)
- Hadrien M. Lalive (ORCID: https://orcid.org/0009-0009-8677-0236)
- Max Scheffler
- Giovanni B. Frisoni
- Chen Wang
Institutions
- University of Geneva (CH)
- University Hospital of Geneva (CH)
- Geneva College (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70862_109698
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00